pembridge podiatry practice ltd Company Information
Company Number
06632195
Next Accounts
Dec 2025
Industry
Other human health activities
Directors
Shareholders
ms maire murphy
Group Structure
View All
Contact
Registered Address
5-7 vernon yard, london, W11 2DX
Website
pembridgepractice.co.ukpembridge podiatry practice ltd Estimated Valuation
Pomanda estimates the enterprise value of PEMBRIDGE PODIATRY PRACTICE LTD at £63.3k based on a Turnover of £141.4k and 0.45x industry multiple (adjusted for size and gross margin).
pembridge podiatry practice ltd Estimated Valuation
Pomanda estimates the enterprise value of PEMBRIDGE PODIATRY PRACTICE LTD at £136.1k based on an EBITDA of £39.8k and a 3.42x industry multiple (adjusted for size and gross margin).
pembridge podiatry practice ltd Estimated Valuation
Pomanda estimates the enterprise value of PEMBRIDGE PODIATRY PRACTICE LTD at £108k based on Net Assets of £44k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pembridge Podiatry Practice Ltd Overview
Pembridge Podiatry Practice Ltd is a live company located in london, W11 2DX with a Companies House number of 06632195. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2008, it's largest shareholder is ms maire murphy with a 100% stake. Pembridge Podiatry Practice Ltd is a established, micro sized company, Pomanda has estimated its turnover at £141.4k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pembridge Podiatry Practice Ltd Health Check
Pomanda's financial health check has awarded Pembridge Podiatry Practice Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £141.4k, make it smaller than the average company (£689.3k)
- Pembridge Podiatry Practice Ltd
£689.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (7.1%)
- Pembridge Podiatry Practice Ltd
7.1% - Industry AVG
Production
with a gross margin of 21.2%, this company has a higher cost of product (36.6%)
- Pembridge Podiatry Practice Ltd
36.6% - Industry AVG
Profitability
an operating margin of 28.1% make it more profitable than the average company (5.1%)
- Pembridge Podiatry Practice Ltd
5.1% - Industry AVG
Employees
with 1 employees, this is below the industry average (18)
1 - Pembridge Podiatry Practice Ltd
18 - Industry AVG
Pay Structure
on an average salary of £25.9k, the company has an equivalent pay structure (£25.9k)
- Pembridge Podiatry Practice Ltd
£25.9k - Industry AVG
Efficiency
resulting in sales per employee of £141.4k, this is more efficient (£45.3k)
- Pembridge Podiatry Practice Ltd
£45.3k - Industry AVG
Debtor Days
it gets paid by customers after 105 days, this is later than average (20 days)
- Pembridge Podiatry Practice Ltd
20 days - Industry AVG
Creditor Days
its suppliers are paid after 76 days, this is slower than average (17 days)
- Pembridge Podiatry Practice Ltd
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pembridge Podiatry Practice Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pembridge Podiatry Practice Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 34.7%, this is a higher level of debt than the average (22%)
34.7% - Pembridge Podiatry Practice Ltd
22% - Industry AVG
PEMBRIDGE PODIATRY PRACTICE LTD financials
Pembridge Podiatry Practice Ltd's latest turnover from March 2024 is estimated at £141.4 thousand and the company has net assets of £44 thousand. According to their latest financial statements, Pembridge Podiatry Practice Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 26,591 | 26,591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,800 | 11,600 | 17,400 | 23,200 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 26,591 | 26,591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,800 | 11,600 | 17,400 | 23,200 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 40,747 | 19,489 | 56,666 | 26,806 | 21,484 | 31,895 | 36,533 | 17,956 | 135 | 197 | 0 | 1,459 | 173 | 7,555 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34,537 | 30,986 | 32,001 | 26,484 | 20,960 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26,344 | 26,342 | 0 | 0 | 0 | 0 | 0 |
total current assets | 40,747 | 19,489 | 56,666 | 26,806 | 21,484 | 31,895 | 36,533 | 17,956 | 26,479 | 26,539 | 34,537 | 32,445 | 32,174 | 34,039 | 20,960 |
total assets | 67,338 | 46,080 | 56,666 | 26,806 | 21,484 | 31,895 | 36,533 | 17,956 | 26,479 | 26,539 | 34,537 | 38,245 | 43,774 | 51,439 | 44,160 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 23,366 | 31,942 | 35,181 | 20,892 | 13,617 | 23,508 | 23,601 | 17,364 | 19,615 | 17,107 | 20,476 | 20,919 | 15,452 | 18,046 | 21,375 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 23,366 | 31,942 | 35,181 | 20,892 | 13,617 | 23,508 | 23,601 | 17,364 | 19,615 | 17,107 | 20,476 | 20,919 | 15,452 | 18,046 | 21,375 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 23,366 | 31,942 | 35,181 | 20,892 | 13,617 | 23,508 | 23,601 | 17,364 | 19,615 | 17,107 | 20,476 | 20,919 | 15,452 | 18,046 | 21,375 |
net assets | 43,972 | 14,138 | 21,485 | 5,914 | 7,867 | 8,387 | 12,932 | 592 | 6,864 | 9,432 | 14,061 | 17,326 | 28,322 | 33,393 | 22,785 |
total shareholders funds | 43,972 | 14,138 | 21,485 | 5,914 | 7,867 | 8,387 | 12,932 | 592 | 6,864 | 9,432 | 14,061 | 17,326 | 28,322 | 33,393 | 22,785 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,766 | 0 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,800 | 5,800 | 5,800 | 5,800 |
Tax | |||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 21,258 | -37,177 | 29,860 | 5,322 | -10,411 | -4,638 | 18,577 | 17,821 | -62 | 197 | -1,459 | 1,286 | -7,382 | 7,555 | 0 |
Creditors | -8,576 | -3,239 | 14,289 | 7,275 | -9,891 | -93 | 6,237 | -2,251 | 2,508 | -3,369 | -443 | 5,467 | -2,594 | -3,329 | 21,375 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34,537 | 3,551 | -1,015 | 5,517 | 5,524 | 20,960 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34,537 | 3,551 | -1,015 | 5,517 | 5,524 | 20,960 |
pembridge podiatry practice ltd Credit Report and Business Information
Pembridge Podiatry Practice Ltd Competitor Analysis
Perform a competitor analysis for pembridge podiatry practice ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in W11 area or any other competitors across 12 key performance metrics.
pembridge podiatry practice ltd Ownership
PEMBRIDGE PODIATRY PRACTICE LTD group structure
Pembridge Podiatry Practice Ltd has no subsidiary companies.
Ultimate parent company
PEMBRIDGE PODIATRY PRACTICE LTD
06632195
pembridge podiatry practice ltd directors
Pembridge Podiatry Practice Ltd currently has 1 director, Ms Maire Murphy serving since Jun 2008.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Maire Murphy | 69 years | Jun 2008 | - | Director |
P&L
March 2024turnover
141.4k
+56%
operating profit
39.8k
0%
gross margin
21.2%
+2.86%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
44k
+2.11%
total assets
67.3k
+0.46%
cash
0
0%
net assets
Total assets minus all liabilities
pembridge podiatry practice ltd company details
company number
06632195
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 2008
age
16
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
5-7 vernon yard, london, W11 2DX
Bank
-
Legal Advisor
-
pembridge podiatry practice ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pembridge podiatry practice ltd.
pembridge podiatry practice ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PEMBRIDGE PODIATRY PRACTICE LTD. This can take several minutes, an email will notify you when this has completed.
pembridge podiatry practice ltd Companies House Filings - See Documents
date | description | view/download |
---|